Endothelial Function and Progenitor Cells in Acute Ischemic Stroke

NCT01289795 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2011-02-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether levels of circulating endothelial progenitor cells (cEPC) are increased in the acute phase of ischemic stroke.

Conditions

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Matthias Endres, MD · Center for Stroke Research Berlin

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2012-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289795 on ClinicalTrials.gov